4521.T | Kaken Pharmaceutical Co., Ltd. Annual & Quarterly

Annual Balance Sheets

(In JPY)

Breakdown	2024	2023	2022	2021	2020	2019
Total Assets	171.62 Billion	166.32 Billion	165.18 Billion	163.33 Billion	157.87 Billion	155.98 Billion
Total Current Assets	106.97 Billion	109.9 Billion	110.61 Billion	113.66 Billion	108.33 Billion	103.73 Billion
Cash And Short Term Investments	65.32 Billion	74.26 Billion	74.62 Billion	77.3 Billion	73.32 Billion	58.55 Billion
Cash and Cash Equivalents	65.32 Billion	59.56 Billion	61.02 Billion	63.7 Billion	59.72 Billion	46.95 Billion
Short Term Investments	14.69 Billion	14.69 Billion	13.59 Billion	13.59 Billion	13.59 Billion	11.59 Billion
Net Receivables	23.74 Billion	19.26 Billion	20.26 Billion	20.54 Billion	21.8 Billion	30.34 Billion
Inventory	17.16 Billion	15.56 Billion	14.98 Billion	15.19 Billion	12.27 Billion	13.71 Billion
Other Current Assets	739 Million	812 Million	749 Million	611 Million	941 Million	1.11 Billion
Total Non-Current Assets	64.64 Billion	56.42 Billion	54.56 Billion	49.66 Billion	49.53 Billion	52.25 Billion
Net PPE	25.35 Billion	25.49 Billion	25.73 Billion	25.02 Billion	25.51 Billion	26.4 Billion
Good Will And Intangible Assets	7.46 Billion	6.74 Billion	8.23 Billion	625 Million	414 Million	551 Million
Good Will	-	-	-	-	-	-
Intangible Assets	7.46 Billion	6.74 Billion	8.23 Billion	625 Million	414 Million	551 Million
Long-Term Investments	20.53 Billion	20.31 Billion	18.87 Billion	22.44 Billion	20.37 Billion	22.36 Billion
Tax Assets	2.59 Billion	3.87 Billion	1.72 Billion	1.57 Billion	3.22 Billion	2.93 Billion
Other Non Current Assets	8.71 Billion	-1 Million	-1 Million	-1 Million	-2 Million	-2 Million
Other Assets	-	2 Million	3 Million	2 Million	4 Million	4 Million
Total Liabilities	27.86 Billion	29.49 Billion	26.85 Billion	27.07 Billion	29.4 Billion	34.85 Billion
Total Current Liabilities	19.02 Billion	20.83 Billion	19.04 Billion	21.27 Billion	21.65 Billion	27.58 Billion
Account Payables	7.09 Billion	6.13 Billion	5.86 Billion	8.42 Billion	7.72 Billion	10.72 Billion
Tax Payables	76 Million	2 Billion	2.43 Billion	2.29 Billion	2.9 Billion	4.04 Billion
Short Term Debt	3.85 Billion	3.85 Billion	3.85 Billion	3.85 Billion	3.85 Billion	3.87 Billion
Deferred Revenue	43 Million	9.38 Billion	7.37 Billion	7.04 Billion	7.73 Billion	9.66 Billion
Other Current Liabilities	8.03 Billion	1.46 Billion	1.96 Billion	1.95 Billion	2.35 Billion	3.31 Billion
Total Non Current Liabilities	8.84 Billion	8.65 Billion	7.8 Billion	5.8 Billion	7.75 Billion	7.27 Billion
Long-Term Debt	-	-	-	-	-	-
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	6.89 Billion	6.88 Billion	5.58 Billion	3.51 Billion	6.26 Billion	5.15 Billion
Other Liabilities	-	-	-	-	-	-
Total Equity	143.75 Billion	136.83 Billion	138.32 Billion	136.25 Billion	128.46 Billion	121.13 Billion
Stock Holders Equity	143.75 Billion	136.25 Billion	137.74 Billion	136.25 Billion	128.46 Billion	121.13 Billion
Common Stock	23.85 Billion	23.85 Billion	23.85 Billion	23.85 Billion	23.85 Billion	23.85 Billion
Retained Earnings	128.5 Billion	126.13 Billion	126.34 Billion	122.46 Billion	114.86 Billion	109.05 Billion
Accumulated other comprehensive income	8.54 Billion	4.88 Billion	4.85 Billion	4.83 Billion	1.71 Billion	3.59 Billion
Common Stock Equity	143.75 Billion	136.25 Billion	137.74 Billion	136.25 Billion	128.46 Billion	121.13 Billion
Capital Lease Obligation	-	-	-	-	-	-
Total Investments	20.53 Billion	17.51 Billion	17.09 Billion	17.36 Billion	15.03 Billion	17.06 Billion
Total Debt	3.85 Billion	3.85 Billion	3.85 Billion	3.85 Billion	3.85 Billion	3.87 Billion
Net Debt	-61.47 Billion	-55.71 Billion	-57.17 Billion	-59.85 Billion	-55.87 Billion	-43.08 Billion

Breakdown	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2	2023 Q1
Total Assets	174.77 Billion	171.62 Billion	171.62 Billion	168.33 Billion	171.65 Billion	167.15 Billion
Total Current Assets	109.07 Billion	106.97 Billion	106.97 Billion	110.33 Billion	112.74 Billion	109.31 Billion
Cash And Short Term Investments	66.56 Billion	65.32 Billion	65.32 Billion	66.15 Billion	70.06 Billion	71.53 Billion
Cash and Cash Equivalents	51.86 Billion	65.32 Billion	65.32 Billion	51.45 Billion	55.36 Billion	56.83 Billion
Short Term Investments	14.69 Billion	14.69 Billion	14.69 Billion	14.69 Billion	14.69 Billion	14.69 Billion
Net Receivables	24.55 Billion	23.74 Billion	23.74 Billion	24.55 Billion	23.99 Billion	20.16 Billion
Inventory	17.08 Billion	17.16 Billion	17.16 Billion	18.87 Billion	17.85 Billion	16.83 Billion
Other Current Assets	868 Million	739 Million	739 Million	753 Million	830 Million	788 Million
Total Non-Current Assets	65.7 Billion	64.64 Billion	64.64 Billion	58 Billion	58.9 Billion	57.83 Billion
Net PPE	26.79 Billion	25.35 Billion	25.35 Billion	24.54 Billion	24.97 Billion	25.05 Billion
Good Will And Intangible Assets	7.39 Billion	7.46 Billion	7.46 Billion	7.48 Billion	7.53 Billion	6.76 Billion
Good Will	-	-	-	-	-	-
Intangible Assets	7.39 Billion	7.46 Billion	7.46 Billion	7.48 Billion	7.53 Billion	6.76 Billion
Long-Term Investments	31.51 Billion	20.53 Billion	20.53 Billion	4.8 Billion	5.32 Billion	26.01 Billion
Tax Assets	-7.39 Billion	2.59 Billion	2.59 Billion	14.69 Billion	14.69 Billion	-6.62 Billion
Other Non Current Assets	7.39 Billion	8.71 Billion	8.71 Billion	6.46 Billion	6.36 Billion	6.62 Billion
Other Assets	-	-	-	2 Million	2 Million	3 Million
Total Liabilities	32.25 Billion	27.86 Billion	27.86 Billion	28.2 Billion	30.92 Billion	29.32 Billion
Total Current Liabilities	23.1 Billion	19.02 Billion	19.02 Billion	19.55 Billion	22.16 Billion	20.46 Billion
Account Payables	7.39 Billion	7.09 Billion	7.09 Billion	8.14 Billion	8.11 Billion	7.07 Billion
Tax Payables	724 Million	76 Million	76 Million	825 Million	1.92 Billion	1.15 Billion
Short Term Debt	3.85 Billion	3.85 Billion	3.85 Billion	3.85 Billion	3.85 Billion	3.85 Billion
Deferred Revenue	724 Million	43 Million	43 Million	1.28 Billion	2.8 Billion	1.61 Billion
Other Current Liabilities	11.13 Billion	8.03 Billion	8.03 Billion	6.26 Billion	7.39 Billion	7.93 Billion
Total Non Current Liabilities	9.15 Billion	8.84 Billion	8.84 Billion	8.65 Billion	8.76 Billion	8.85 Billion
Long-Term Debt	-	-	-	-	-	-
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	7.21 Billion	6.89 Billion	6.89 Billion	6.88 Billion	6.99 Billion	7.08 Billion
Other Liabilities	-	-	-	-	-	-
Total Equity	142.51 Billion	143.75 Billion	143.75 Billion	140.13 Billion	140.72 Billion	137.83 Billion
Stock Holders Equity	142.51 Billion	143.75 Billion	143.75 Billion	140.13 Billion	140.72 Billion	137.25 Billion
Common Stock	23.85 Billion	23.85 Billion	23.85 Billion	23.85 Billion	23.85 Billion	23.85 Billion
Retained Earnings	127.41 Billion	128.5 Billion	128.5 Billion	127.15 Billion	127.39 Billion	125.83 Billion
Accumulated other comprehensive income	8.4 Billion	8.54 Billion	8.54 Billion	6.27 Billion	6.63 Billion	6.18 Billion
Common Stock Equity	142.51 Billion	143.75 Billion	143.75 Billion	140.13 Billion	140.72 Billion	137.25 Billion
Capital Lease Obligation	-	-	-	-	-	-
Total Investments	46.21 Billion	20.53 Billion	20.53 Billion	19.5 Billion	20.02 Billion	19.38 Billion
Total Debt	3.85 Billion	3.85 Billion	3.85 Billion	3.85 Billion	3.85 Billion	3.85 Billion
Net Debt	-48.01 Billion	-61.47 Billion	-61.47 Billion	-47.6 Billion	-51.51 Billion	-52.98 Billion

Balance Sheet Charts

Sahara International Petrochemical Company

2310

Full Analysis

Annual Balance Sheets
Illumina, Inc.

ILU

Full Analysis

Annual Balance Sheets
Cardinal Health, Inc.

0HTG

Full Analysis

Annual Balance Sheets
Capital Securities Corporation

6005

Full Analysis

Annual Balance Sheets
Hawaiian Holdings, Inc.

0J3N

Full Analysis

Annual Balance Sheets
BellRock Brands Inc.

DXBRF

Full Analysis

Annual Balance Sheets

Global Stocks Search

Kaken Pharmaceutical Co., Ltd. (4521.T)

Annual Balance Sheets

Balance Sheet Charts

Sahara International Petrochemical Company

Illumina, Inc.

Cardinal Health, Inc.

Capital Securities Corporation

Hawaiian Holdings, Inc.

BellRock Brands Inc.